(Q39961988)

15 September 2017

title

Should active injecting drug users receive treatment for chronic hepatitis C? (English)

1 reference

15 September 2017

1 reference

Vasileios Papadopoulos

1

1 reference

15 September 2017

Aikaterini Gogou

2

1 reference

15 September 2017

Theodora Mylopoulou

3

1 reference

15 September 2017

Konstantinos Mimidis

4

1 reference

15 September 2017

publication date

1 July 2010

1 reference

Arquivos de Gastroenterologia

15 September 2017

published in

1 reference

15 September 2017

volume

47

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

238-241

1 reference

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Need-adapted HCV-treatment setting for injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Acute hepatitis C: current status and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Treatment of chronic hepatitis C in Asia: when East meets West.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032010000300005

10.1590/S0004-28032010000300005

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference